Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Deferred Taxes: 2019-2024

Historic Deferred Taxes for Revolution Medicines (RVMD) over the last 5 years, with Dec 2024 value amounting to $762,000.

  • Revolution Medicines' Deferred Taxes rose 1672.09% to $762,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $569,000, marking a year-over-year increase of 425.14%. This contributed to the annual value of $762,000 for FY2024, which is 80.51% down from last year.
  • Per Revolution Medicines' latest filing, its Deferred Taxes stood at $762,000 for FY2024, which was down 80.51% from $3.9 million recorded in FY2023.
  • In the past 5 years, Revolution Medicines' Deferred Taxes registered a high of $3.9 million during FY2023, and its lowest value of $375,000 during FY2020.
  • For the 3-year period, Revolution Medicines' Deferred Taxes averaged around $1.7 million, with its median value being $762,000 (2024).
  • Per our database at Business Quant, Revolution Medicines' Deferred Taxes plummeted by 91.42% in 2020 and then surged by 833.17% in 2023.
  • Revolution Medicines' Deferred Taxes (Yearly) stood at $375,000 in 2020, then reached $419,000 in 2022, then surged by 833.17% to $3.9 million in 2023, then tumbled by 80.51% to $762,000 in 2024.